首页 | 本学科首页   官方微博 | 高级检索  
检索        


Ameliorating effects of Nigella sativa oil on aggravation of inflammation,oxidative stress and cytotoxicity induced by smokeless tobacco extract in an allergic asthma model in Wistar rats
Authors:T Khaldi  N Chekchaki  M Boumendjel  F Taibi  M Abdellaoui  M Messarah  A Boumendjel
Institution:Laboratory of Biochemistry and Environmental Toxicology, Department of Biochemistry, Faculty of Sciences, Badji Mokhtar University, Annaba, Algeria
Abstract:

Background

The comparison of smokeless tobacco (ST) exposure versus Ovalbumin (Ova) sensitized rats or asthmatic patients has hardly been studied in the literature. Thus, the present study aims to investigate the aggravation of inflammation, exacerbation of asthma, oxidative stress and cytotoxicity induced by ST.

Methods

ST was given at the dose of 40 mg/kg in an allergic asthma model in Wistar rats. Furthermore, the effects of oral administration of Nigella sativa oil (NSO), at a dose of 4 mL/kg/day, were investigated.

Results

The obtained results showed that ST clearly enhanced lung inflammation through interleukin-4 (IL-4) and Nitric oxide (NO) increased production. Actually, ST was found to intensify the oxidative stress state induced by Ova-challenge in rats, which was proven not only by augmenting lipid peroxidation and protein oxidation, but also by altering the non-enzymatic and enzymatic antioxidant status. Furthermore, the aggravation of inflammation and oxidative stress was obviously demonstrated by the histopathological changes observed in lung. In contrast, NSO administration has shown anti-inflammatory effects by reducing IL-4 and NO production, restoring the antioxidant status, reducing lipid peroxidation and improving the histopathological alterations by both protein oxidation and NSO treatment.

Conclusions

Our data have proven that severe concurrent exposure to allergen and ST increases airway inflammation and oxidative stress in previously sensitized rats. They also suggest that the oral NSO treatment could be a promising treatment for asthma.
Keywords:AHR  airway hyperresponsiveness  b  w    body weight  BALF  BronchoAlveolar Lavage Fluid  CAT  catalase  DGRSDT  (in Frensh Direction Générale de la Recherche Scientifique et du Développement Technologique) General Directorate for Scientific Research and Technological Development  DNPH  2  4-dinitrophenylhydrazine  DTNB  5  5′-dithiobis-(2nitrobenzoic acid)  ELISA  enzyme-linked immunosorbent assay  GPx  glutathione peroxidase  GSH  reduced glutathione  IFN-γ  interferon gamma  IgE  immunoglobulin E  IL-4  interleukin-4  LD50  median lethal dose  LPO  lipid peroxidation  MDA  MalonDiAldehyde  NBT  nitro blue tetrazolium  NO  nitric oxide  NPSH  non-protein thiols  NSO  ONAB  (in Frensh Office National des Aliments de Bétails) National Livestock Feed Office  Ova  Ovalbumin  PBS  phosphate buffer solution  ROS  reactive oxygen species  SEM  standard error mean  SOD  superoxide dismutase  ST  smokeless tobacco  STE  smokeless tobacco extract  TBA  thiobarbituric acid  TBARS  thiobarbituric reactive species  Th1  T helper cell 1  Th2  T helper cell 2  TQ  thymoquinone  Smokeless tobacco  Experimental asthma  Airway inflammation  Oxidative stress  Wistar rats
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号